Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure.

BACKGROUND Alpha-melanocyte-stimulating hormone (alpha-MSH), a pro-opiomelanocortin (POMC) derivative, is a neuropeptide with potent anti-inflammatory properties that inhibits tissue injury in a wide array of inflammation models. OBJECTIVE To determine if alpha-MSH is involved in the development of congestive heart failure (CHF) with the specific aim of examining its peripheral source and one of the mechanisms. METHODS The circulating levels of alpha-MSH were measured in 115 patients with CHF using a double-antibody radioimmunoassay. To determine one of the sources of circulating alpha-MSH, human peripheral blood mononuclear cells (PBMC) were stimulated with lipopolysaccharide (LPS) or tumor necrosis factor (TNF)-alpha. Furthermore, to clarify one of the functions of alpha-MSH, PBMC were cultured in the presence or absence of alpha-MSH. RESULTS Plasma levels of alpha-MSH were significantly higher in NYHA class II patients with CHF than in control subjects (p<0.0001). A significant correlation was found between the levels of alpha-MSH and high-sensitive testing for C-reactive protein in patients with CHF (r=0.41, p<0.0005). PBMC stimulated with LPS or TNF-alpha released alpha-MSH in a concentration-dependent manner. alpha-MSH inhibited LPS-induced TNF-alpha production, and alpha-MSH simultaneously augmented production of interleukin (IL)-10 by PBMC. CONCLUSIONS Circulating alpha-MSH was increased in patients with CHF. Inflammatory response induced alpha-MSH production in cultured human PBMC. Treatment of alpha-MSH could modify the immunobalance between inflammatory and anti-inflammatory responses in cultured PBMC. These findings suggest that alpha-MSH may play an important role in the pathophysiology of CHF.

[1]  S. Goh,et al.  α-Melanocyte-stimulating Hormone Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-α Production in Leukocytes by Modulating Protein Kinase A, p38 Kinase, and Nuclear Factor κB Signaling Pathways* , 2003, Journal of Biological Chemistry.

[2]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[3]  M. Yamaoka-Tojo,et al.  Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. , 2002, Journal of cardiac failure.

[4]  J. Miyazaki,et al.  Protection Against Autoimmune Myocarditis by Gene Transfer of Interleukin-10 by Electroporation , 2001, Circulation.

[5]  J. M. Lipton,et al.  α-Melanocyte-stimulating Hormone in Normal Human Physiology and Disease States , 2000, Trends in Endocrinology & Metabolism.

[6]  J. M. Lipton,et al.  Plasma concentrations of alpha-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  J. Haycock,et al.  α-Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines* , 2000, The Journal of Biological Chemistry.

[8]  J. M. Lipton,et al.  Plasma concentrations and anti‐L‐cytokine effects of α‐melanocyte stimulating hormone in septic patients , 2000, Critical care medicine.

[9]  S. Yamaguchi,et al.  Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha. , 1999, Japanese circulation journal.

[10]  J. M. Lipton,et al.  α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  J. M. Lipton,et al.  Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. , 1999, The Journal of laboratory and clinical medicine.

[12]  S. Frøland,et al.  Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1999, The American journal of cardiology.

[13]  S. Manna,et al.  α-Melanocyte-Stimulating Hormone Inhibits the Nuclear Transcription Factor NF-κB Activation Induced by Various Inflammatory Agents , 1998, The Journal of Immunology.

[14]  J. M. Lipton,et al.  Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients , 1998, Peptides.

[15]  J. M. Lipton,et al.  Mechanisms of Antiinflammatory Action of the Neuroimmunomodulatory Peptide α‐MSH , 1998 .

[16]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[17]  J. M. Lipton,et al.  α-MSH Modulates Local and Circulating Tumor Necrosis Factor-α in Experimental Brain Inflammation , 1997, The Journal of Neuroscience.

[18]  J. M. Lipton,et al.  Anti-inflammatory actions of the neuroimmunomodulator α-MSH , 1997 .

[19]  T. LeJemtel,et al.  Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.

[20]  Edouard Vannier,et al.  Clinical, hematologic, and immunologic effects of interleukin-10 in humans , 1996, Journal of Clinical Immunology.

[21]  Y. Aragane,et al.  Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. , 1996, Journal of immunology.

[22]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[23]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[24]  J. M. Lipton,et al.  α‐MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line , 1996 .

[25]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[26]  A. Matsumori,et al.  Increased circulating cytokines in patients with myocarditis and cardiomyopathy. , 1994, British heart journal.

[27]  L. Vaca,et al.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.

[28]  W. Millington,et al.  Characterization of β-endorphin- and α-MSH-related peptides in rat heart , 1993, Peptides.

[29]  G. Morris,et al.  Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.

[30]  W. Millington,et al.  Proopiomelanocortin‐Derived Peptides and mRNA Are Expressed in Rat Heart , 1993, Annals of the New York Academy of Sciences.

[31]  F. Trautinger,et al.  Production of Immunosuppressing Melanotropins By Human Keratinocytes a , 1993, Annals of the New York Academy of Sciences.

[32]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[33]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[34]  S. Goh,et al.  alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. , 2003, The Journal of biological chemistry.

[35]  S. Manna,et al.  Agents Activation Induced by Various Inflammatory B κ the Nuclear Transcription Factor NF-- Melanocyte-Stimulating Hormone Inhibits α , 1998 .

[36]  J. M. Lipton,et al.  alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. , 1997, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  A. Catania,et al.  alpha-Melanocyte stimulating hormone in the modulation of host reactions. , 1993, Endocrine reviews.